From Kron4:
In the latest development tied to the disturbing and often harmful practice of “looksmaxxing” among young men, teenagers are now reportedly taking cancer drugs in an effort to grow taller. The trend is known as “heightmaxxing,” and according to a report in Rolling Stone, it centers around a cancer drug known as erdafitinib.
Erdafitinib is sold under the brand name of Balversa and was approved in the U.S. in 2019 as a prescription drug to treat locally advanced metastatic urothelial cancer in certain adults. The drug blocks proteins known as fibroblast factor receptors (FGFRs) that play a role in cell growth regulation. Side effects of erdafitinib include bladder pain, blurred vision, confusion, chest tightness, labored breathing, lower back pain, seizures, scaling of the skin on the hands and feet, irregular heartbeat, and loosening of the fingernails, according to drugs.com.